IL38235A - Triglyceride hydrolysis and assay - Google Patents

Triglyceride hydrolysis and assay

Info

Publication number
IL38235A
IL38235A IL38235A IL3823571A IL38235A IL 38235 A IL38235 A IL 38235A IL 38235 A IL38235 A IL 38235A IL 3823571 A IL3823571 A IL 3823571A IL 38235 A IL38235 A IL 38235A
Authority
IL
Israel
Prior art keywords
accordance
glycerol
lipase
nadh
protease
Prior art date
Application number
IL38235A
Other versions
IL38235A0 (en
Original Assignee
Calbiochem
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Calbiochem filed Critical Calbiochem
Publication of IL38235A0 publication Critical patent/IL38235A0/en
Publication of IL38235A publication Critical patent/IL38235A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/61—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving triglycerides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/44—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving esterase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/02—Food
    • G01N33/04—Dairy products
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/886—Streptomyces
    • Y10S435/897—Streptomyces griseus
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/911—Microorganisms using fungi
    • Y10S435/939—Rhizopus

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Description

Triglyceride hydrolyeis and assay CALBIOCHBM This invention relates to a rapid method of determining 'ψ-fatty acid glycerol esters in various aqueous media, such as serum, milk, and the like.
In many fields, but particularly in clinical biochemistry, it is important to determine the content of fatty acid esters of glycerol in a particular sample. The assay is of particular importance in human serum, where elevated levels are of great diagnostic value. Methods depending upon determination of the fatty acid moiety, and methods in which glycerol liberated from other sources contributes to the total assay, have various disadvantages. A rapid, accurate method operating exclusively and at the same time completely on the fatty acid glycerol esters is an important desideratum in the clinical field, and prior art methods are in general not fully satisfactory.
An object of the present invention is to provide a rapid and accurate procedure which liberates glycerol from its esterified form as a fatty acid ester, for example when present in aqueous media such as serum, and which permits the glycerol to be .assayed by a variety of alternative methods without the necessity of isolating the glycerol, from the medium under test.
Other objects of the invention will appear as the descrip-tion thereof proceeds.
Generally speaking, and in accordance with illustrative embodiments of our invention, we add to an aqueous medium con-taining the fatty acid glycerol to be gssayed, a mixture of first a lipase, v/hich may be of plant or animal . origin, but among which we prefer and find best a microbial lipase, such as the lipase from Chromobacterium viscosum, variant paralipolyticum, crude or puri ied the lipase from Rhizopus delemar, purified, for example as noted in Fukumoto et al., J. Gen. Appl. Microbiol., 10, 257-265 (1954); anJ lipases having similar activity; and second, a protease. Proteases in general may be used, such as by way of example and not by limitation, chymotrypsin, trypsin, Streptomyces griseus protease (commercially available under the registered trademark "Pronase" ), elastase, papain, and bromelin. Mixtures of these may also be employed. This simple enzyme mixture is in general sufficient, although the hydrolysis may generally be expedited somewhat by the simultaneous inclusion of a simple protein such as serum albumin, egg albumin, globulins, and the like.
As will be set forth in detail hereinbelow, the glycerol liberated by the action of the enzyme mixture just described may be assayed in a number of ways, although we prefer one in particular which will now be described.
We prefer to carry out the enzymatic hydrolysis of the triglycerides by the lipase-protease combination as just described in the presence of the components of three additional enzymatic transformation systems, whereby first-, the glycerol which has been liberated is converted to a -glycerol phosphate by glycerol kinase with the simultaneous conversion of adenosine triphosphate to adenosine diphosphate; second, the conversion of the latter back to adenosine triphosphate with the simultaneous conversion of phosphoenolpyruvic acid to pyruvate ion under the action of pyruvate kinase; and third, the conversion of the pyruvate ion to lactate ion with the simultaneous conversion of nicotinamide adenine dinucleotide from its reduced to its oxidized form, under the action of lactate dehydrogenase. All of these system components are present simultaneously in the mixture, so that as the hydrolysis of the triglyceride proceeds, the optical density of the solution at 3^0 nanometers decreases a3 a result of the oxidation of the dinucleotide. This sequence of enzymatic con Triglycerides enzymatic—v Glycerol +· JEF. A, ° hydrolysis 7 Glycerol + ATP GK _ Of-GP + ADP ADP + PEP ffi, ATP -- Pyruvate Pyruvate - NADH > Lactate NAD C-colored | (co^lorle'ssi at 3^0 run) |at 340 Abbreviations: PPA = Free fatty acids ATP » Adenosine triphosphate ^f-GP - c*-Glycerol phosphate ADP - Adenosine diphosphate PEP * Phosphoenolpyruvic acid LDH = Lactate dehydrogenase OK = Glycerol kinase PK Pyruvate kinase NAD and NADH Nicotinamide adenine dinucleotide, oxidized and reduced * I.e., absorbs strongly at 3^0 nm; molar extinction coefficient a M = 6,22 X 103.
** I.e., transparent at 3 0 nm.
- · ' V A useful and preferred embodiment of our invention comprises an assay mixture containing the preferred constituents to carry out a single triglyceride assay in accordance with the invention. Inasmuch as the preferred procedure involves the enzymatic hydrolysis as already described using the enzyme combination disclosed, followed by the conversion of the liberated glycerol as likevfise described, it is convenient to furnish the assay mixture in two separate containers, such as glass vials, one of which, which may be termed "Vial A" for convenience, may contain all the components needed for the assay except the glycerol kinase. The latter may be placed in Vial B. Of course, other distributions of the components are possible, any of those involved solely with the glycerol conversion and subsequent steps being includable in Vial B if desired. However, we prefer and find best the following reaction mixture: Vial A Potassium phosphate buffer, 0.1M, pH Magnesium, aspartate 1.6 mg ATP disodium 0.9 uM Phosphoenol pyruvate ; 0.9 uM Bovine serum albumin 5.0 mg NADH to a final absorbance of 0.8 (optical density at 340 ran) LDH 2 I.U.
Pyruvate kinase 6 I.U. o -Chymotrypsin 1100 N.P. units Lipase, Rhizopus delemar 1200 lipase units (Total volume: 3 ml) (One (l) lipase unit is the quantity of enzyme which will release fatty acids from a substrate of triolein to require 1 ml of 0.05N potassium hydroxide for neutralization after a 30-min. incubation period at 37°C.) (One (l) N.F. unit of o -chymotrypain is that quantity *~ of enzyme which will produce an abaorbance change of 0.0075/minute at 237 nanometers when incubated with a substrate of N-acetyl-L-tyrosine ethyl ester under the conditions of assay.) Vial B Glycerol kinase: 2 I.U. (International Units).
The assay in accordance with the invention is carried out by adding an aliquot of liquid containing the triglyceride to be assayed, which may be for example 50 μΐ of serum, to the 3 ml contents of Vial A. This is then incubated at between 25°C. and 37°C. for approximately ten minutes. The optical density is then determined at 3^0 nm. Then the 2 I.U. of glycerol kinase contained in Vial B is added, and the mixture allowed to stand for an additional 10 minutes at the same temperature, whereupon the optical density is determined again. The difference is proportional to the triglyceride content of the aliquot.
It may be noted that the essential contents of the reaction mixture in accordance with the invention, especially as packaged for single assays, comprises a microbial lipase; a protease; pyruvate kinase; lactate dehydrogenase; NADH; ATP; phosphoenol pyruvate; a magnesium ion source; a buffer; and glycerol kinase.
• An alternative procedure consists in omitting the NADH and the lactate dehydrogenase from the mixture described above, so that only the first three reaction steps depicted hereinabove occur; and adding a sufficient quantity of dinitrophenyl hydrazine to react with the pyruvate ion formed in the aforementioned third reaction step. The reaction product is colored when alkalized, and may be readily measured by a colorimeter.
A further alternative procedure is to omit the phos-phoenol pyruvate; the pyruvate kinase; and the lactate dehydrogenase from the reaction mixture previously described, and to add instead glycerol phosphate dehydrogenase, whereupon the a -glycerol phosphate and the NAD are converted respectively to dihydroxyacetone phosphate and NADH. The amount of NADH formed, which is proportional to the amount of triglyceride originally present, can conveniently be measured by the increase in luorescence. An alternative sub-procedure is to include also a sufficient quantity of dinitrophenyl hydrazine in this system as well which will result in the formation of a colored reaction product with the dihydroxyacetone phosphate liberated. The amount of the reaction product can then readily be determined with a colorimeter and is likewise a measure of the triglyceride originally present.
A still further alternative procedure is to utilize a reaction mixture which provides only the enzymatic conversion to glycerol which is the first reaction step set orth in the tabulation hereinabove. The reaction mixture, however, also includes NAD and glycerol dehydrogenase. As a result, the glycerol which is liberated in the first step is converted to dihydroxyacetone with the simultaneous production of NADH. The increase in optical density at 3^0 nm then becomes a measure of the quantity of triglyceride originally present, as previously described. A suitable glycerol dehydrogenase is that obtainable from Enterobacter aerogenes; this enzyme is commercially available. An alternative subprocedure here is to add dinitrophenyl hydrazine, which forms a colored reaction product with the dihydroxy acetone, so that the latter may then be measured colorlmetrlcally.
In the two alternative procedures just described, viz., in the first of which glycerol phosphate dehydrogenase and in the second of which glycerol dehydrogenase, respectively, are used, an equivalent amount of NADH is formed, as already mentioned. A further alternative sub-procedure applicable to both of these is to utilize the known behavior of various tetrazolium salts, which upon reduction are converted from colorless, water-soluble compounds to colored dyes. The NADH which is quantitatively formed from the triglyceride may be caused to transfer its hydrogen (becoming oxidized in the process) to the tetrazolium salt, again quantitatively, through the mediation of any of several known substances, among which we prefer especially diaphorase or, alternatively, phenazine methosulfate. The amount of dye thus formed may be readily measured by colorimetry, i.e., by carrying out optical density change measurements in the visible region.
It is not believed necessary to spell out the details of these alternative sub-procedures jus "described, since they are fully documented in the literature. Representative articles, which together with the literature cited therein are hereby incorporated herein by reference, are the following: American Journal of Clinical Pathology, Vol. 45, No. 5, May, 1966: "Rapid Colorimetric (Tetrazolium Salt) Assa for Lactate Dehydrogenase", by R. 0. Briere, J. A. Preston, and J. G. Batsakis.
"Methods of Enzymatic Analysis" by H. U.
Bergmeyer, New York: Academic Press, 1 5; pages 953-955.
Coming now to the relative proportions of the selected lipase (or mixture of selected lipases) and the selected protease (or mixture thereof), we prefer that for each 1000 lipase units present in the assay mixture, there be present from about 5 to about 500 international units of protease. V/e find best a subrange therein of about 20 to about 100 I.U. (international units) of protease.
The lipase unit has been defined hereinabove. The international unit of proteolytic activity is the amount of protease which causes a turnover of one micromol per minute of a substrate which is specific for the particular enzyme in question, under conditions approximating an optimum for the system considered. Thus, for chymotrypsin the substrate is tyrosine ethyl ester, and the turnover rate may be determined in any number of ways, as by the change in optical density at 237 nm, or by determining the amino acid liberated, as phenol reagent tyrosine equivalents or by formol titration.
The N.P. (National Formulary) unit is occasionally used for proteases, and appears in an example hereinabove. Since 1 NkP. unit is equivalent to ^8 I.U., it will be seen that the 1100 N.F. units of chymotrypsin in the example is equal to 39 I.U. Since.1200 lipase units were present in the exemplary mixture, it will be seen that for each 1000 lipase units, our example shows about 3 I.U. of protease.
The lipase-protease mixture in accordance with the invention, and particularly the mixture o Rhizopus delemar lipase and a -chymotrypsin, particularly within the range of relative proportions noted herein, is quite generally useful in clinical laboratory practice as a fat-clearing agent, whenever triglycerides are present.
It will be clear from the foregoing that in distributing the components of our preferred assay mixture between Vial A and Vial B, one of the vials, e.g., Vial A, should contain at least the lipase and the protease; whereas the second vial, e.g»> Vial B, should contain at least the glycerol kinase.
The remaining components may be distributed as desired between the two vials. Our preferred distribution, however, has been set forth hereinabove.
In proceeding in accordance with the invention as has been disclosed hereinabove, it will be found that the glycerol esters are completely hydrolyzed, so that a stoichiometric amount of glycerol is liberated, as indeed has already been explained. We are unable to offer an explanation of the. underlying mechanism whereby this is accomplished, but it is clear that it stems from the conjoint presence of the lipase • with the protease, all as described and specified. For example, when proceeding. in accordance with the detailed example given hereinabove, and when the aqueous medium under test is human serum^ it is found that the glycerol liberated is that quantity to be expected on the basis of complete hydrolysis of the triglycerides present, the latter being determined by standard procedures well known in the art.
Those skilled in the art will recognize that a -glycerol phosphate may also be named as glycerol-l-phosphate; and that the fatty acid glycerol esters in serum may be and generally are referred to simply as "triglycerides".
As will be clear from the explanations given hereinabove, one unit of lipase meane the amount of lipase equivalent to one lipase unit as specified hereinabove.
We wish it to be understood mat we. do not desire to be limited to the exact details of components and procedures shown and described, for obvious modifications will occur to a person skilled in the art.

Claims (3)

The embodiments of the invention in which an exclusive property or privilege is claimed are defined as follows:
1. In a process of assaying an aqueous liquid containing a fatty acid glycerol ester for its content of said ester in which said ester is hydrolyzed to liberate all of said glycerol followed by determining the amount of glycerol present, the improvement which consists in effecting said hydrolysis by adding both a lipase and a protease to said liquid, whereby substantially complete hydrolysis of said ester is caused to take place.
2. A process in accordance with Claim 1 wherein said lipase is microbial. 3. A process in accordance with Claim 2 wherein said lipase is chosen from the class consisting of Rhizopus delemar and Chromobacterium viscosum lipases, and mixtures thereof. 4. A process in accordance with Claim 1 wherein said protease is chosen from the class consisting of chymo-trypsin, trypsin, streptomyces griseus protease, elastase, papain, bromelin, and mixtures thereof. 5. A process in accordance with Claim 3 in which said protease is chosen from the class consisting of chymo-trypsin, trypsin, Streptomyces griseus protease, elastase, papain, bromelin, and mixtures thereof. 6. A process in accordance with Claim 1 wherein from about 5 to about 50C I.U. of said protease is present for each 1000 units of said lipase. 7. A process in accordance with Claim 2 wherein from about 5 to about 500 I.U. of said protease is present for each 1000 units of said lipase. 8. A process in accordance with Claim 5 wherein from about 5 to about 500 I.U. of said protease is present for each 1000 units of said lipase. 9« A process in accordance with Claim 1 wherein said liquid is serum, and said glycerol ester is serum triglyceride. 10. A process in accordance with Claim 1 wherein, subsequent to said liberation of glycerol, adenosine triphosphate and glycerol kinase are added to said liquid in sufficient quantity to convert said glycerol to glycerol-l-phosphate and said adenosine triphosphate to adenosine diphosphate; and in which said adenosine diphosphate is assayed, whereby the original content of said fatty acid "glycerol ester may be determined. 11. A process in accordance with Claim 10 wherein to said aqueous liquid containing said glycerol-l-phosphate, nicotinamide adenine dinucleotide and glycerol phosphate dehydrogenase are added in sufficient quantity to convert said glycerol-l-phosphate and said NAD to dihydroxyacetone phosphate and nicotinamide adenine dinucleotide, reduced (NADH) respectively. 12. The process in accordance with Claim 11 wherein said NADH is assayed by fluorimetry. 13. A process in accordance with Claim 10 wherein to said aqueous liquid containing said glycerol-l-phosphate in said ADP, there are added phosphoenol pyruvate and pyruvate kinase in sufficient quantity to convert said phosphoenol pyruvate to pyruvate ion, and in which said pyruvate ion is assayed to give an indication of the amount of said glycerol ester originally present. 14. A process in accordance with Claim 13 wherein said pyruvate is assayed by adding to said aqueous liquid a sufficient quantity of dinitrophenyl hydrazine to react therewith, whereby a colored compound is formed. 15. A process in accordance with Claim 13 wherein to said aqueous liquid containing said pyruvate ion there are added NADH and lactate dehydrogenase in sufficient quantity to convert said pyruvate and said NADH to lactate ion and NAD respectively. 16. The process in accordance with Claim 15 in which the concentration of said NAD in said aqueous liquid is determined by measuring the change in optical density thereof at approximately 3^0 nanometers. 17. The process in accordance with Claim 1 wherein, subsequent to said liberation of glycerol, adenosine triphosphate and glycerol kinase are added to said liquid in sufficient quantity to convert said glycerol to glycerol-l-phosphate and said adenosine triphosphate to adenosine diphosphate; and in which said glycerol-l-phosphate is assayed, whereby the original content of said fatty acid glycerol ester may be determined. 18. A process in accordance with Claim 17 wherein said glycerol-1-phosphate is assayed by adding to said liquid NAD and glycerol phoephate dehydrogenase, whereby said glycerol-1-phosphate is converted to dihydroxyacetone phosphate and said NAD is converted to NADH; and wherein at least one of said conversion products is assayed to give a measure of the fatty acid glycerol ester originally present. 19. The process in accordance with Claim l8 wherein said NADH is measured by determining the increase in fluorescence of said solution. 20. The process in accordance with Claim l8 wherein dinitrophenyl hydrazine is added to said liquid, whereby a colored reaction product is formed with said dihydroxyacetone phosphate and wherein the intensity of color produced in said solution is determined as a measure of the dihydroxyacetone phosphate. 21 The process in accordance with Claim 1 wherein to sa.id liquid there is added NAD and glycerol dehydrogenase, whereby said glycerol is converted to dihydroxyacetone and said NAD is converted to NADH; and in which said NADH is assayed to give a measure of the fatty acid glycerol ester originally present. 22. The process in accordance with Claim 11 wherein to said aqueous liquid containing said NADH, a tetrazolium salt is added together with a hydrogen transfer agent for said tetrazolium salt, whereby the latter is quantitatively converted to a colored dye with concomitant oxidation of said NADH. 23. The process in accordance with Claim 22 wherein said hydrogen transfer agent is selected from the class consisting of diaphorase and phenazine methosulfate. 24. The process in accordance with Claim 21 wherein to said aqueous liquid containing said NADH, a tetrazolium salt is added together with a hydrogen transfer agent for said tetrazolium salt, whereby the latter is quantitatively converted to a colored dye with concomitant oxidation of said NADH. 25. The process in accordance with Claim 24, wherein said hydrogen transfer agent is selected from the class consisting of diaphorase and phenazine methosulfate. 26. The process in accordance with Claim 21 wherein said glycerol dehydrogenase is derived from Enterobacter-aerogenes. 27. The process in accordance with Claim 21 wherein said NADH is; assayed by determining the increase in optical density at 340 nm. 28. A reagent combination for the analysis of fatty in accordance with the process claimed in Claim 1 acid glycerol esters"7which comprises a first vial containing a lipase and a protease; a second vial containing glycerol kinase; and pyruvate kinase; lactate dehydrogenase; NADH; ATP; phosphoenol pyruvate; a magnesium ion source; and a buffer in any preselected distribution in said vials. 29. A reagent combination in accordance with Claim 28 wherein from about to about 500 I.U. of said protease is present for each 1000 units of said lipase. 30. A reagent combination in accordance with Claim 28 wherein said lipase is a microbial lipase. 31. A reagent combination in accordance with Claim 29 wherein said lipase is a microbial lipase. 32. A reagent combination in accordance with Claim 28 wherein said lipase is derived from Rhizopus delemar; said protease is a -chymotrypsin; said magnesium ion source is magnesium aspartate; and said buffer is pH 7 potassium buffer. 33. A reagent combination in accordance with Claim 32 wherein from about 5 to about 500 I.U. of said protease is present for each 1000 units of said lipase.
3. . A lipase-protease combination for the enzymatic in a process as claimed in Claim 1 hydrolysis of triglycerides/comprising Rhizopus-' delemar lipase and a -chymotrypsin. 35* A combination in accordance with Claim 3 in which for each 1, 000 lipase units of said lipase, there are present :from about 5 to about 500 international units of said a -chymotrypsin.
IL38235A 1970-12-16 1971-11-26 Triglyceride hydrolysis and assay IL38235A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US9890470A 1970-12-16 1970-12-16

Publications (2)

Publication Number Publication Date
IL38235A0 IL38235A0 (en) 1972-01-27
IL38235A true IL38235A (en) 1974-10-22

Family

ID=22271481

Family Applications (1)

Application Number Title Priority Date Filing Date
IL38235A IL38235A (en) 1970-12-16 1971-11-26 Triglyceride hydrolysis and assay

Country Status (17)

Country Link
US (1) US3703591A (en)
JP (2) JPS549518B1 (en)
AU (1) AU475955B2 (en)
BE (1) BE776034A (en)
BR (1) BR7108185D0 (en)
CA (1) CA955161A (en)
CH (2) CH563404A5 (en)
CS (1) CS212729B2 (en)
DE (1) DE2162325C3 (en)
ES (1) ES395956A1 (en)
FR (1) FR2118454A5 (en)
GB (1) GB1373106A (en)
IL (1) IL38235A (en)
IT (1) IT972079B (en)
NL (1) NL180523C (en)
SE (1) SE389919B (en)
ZA (1) ZA717957B (en)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2101796A1 (en) * 1970-01-21 1971-08-05 Baxter Laboratories Inc Method for the determination of glycene in blood serum
AT324282B (en) * 1972-06-19 1975-08-25 Boehringer Mannheim Gmbh METHOD AND REAGENT FOR DETERMINATION OF TRIGLYCERIDES
CS164231B2 (en) * 1972-09-28 1975-11-07
JPS49113695A (en) * 1973-02-27 1974-10-30
AT339505B (en) * 1974-03-14 1977-10-25 Boehringer Mannheim Gmbh ENZYMATIC ANALYSIS PROCEDURE
US3898130A (en) * 1974-03-18 1975-08-05 American Hospital Supply Corp Rapid enzymatic hydrolysis of triglycerides
CA1029644A (en) * 1974-03-20 1978-04-18 The Dow Chemical Company Method for determination of triglycerides and glycerol
CA1056282A (en) * 1974-03-25 1979-06-12 Charles T. Goodhue Multilayer analytical elements for use in the assay of cholesterol
US3884764A (en) * 1974-03-25 1975-05-20 Eastman Kodak Co Method and composition for blood serum cholesterol analysis
JPS50142090A (en) * 1974-04-30 1975-11-15
JPS5169691A (en) * 1974-06-07 1976-06-16 Iatron Lab Ketsuseichuno chuseishibosokuteiyoshaku
US4014744A (en) * 1975-01-30 1977-03-29 Miles Laboratories Inc. Processes for measuring tri-, di- and monoglycerides
US4011045A (en) * 1975-02-14 1977-03-08 Bonderman Dean P Turbidity reduction in triglyceride standards
JPS5217085A (en) * 1975-07-30 1977-02-08 Ono Pharmaceut Co Ltd Method of quantitative determination of free fatty acids in serum usin g fatty acid activating enzymes
US4012287A (en) * 1975-11-18 1977-03-15 Dr. Bruno Lange Gmbh Method and reagent for the quantitative analysis of triglycerides
US4045297A (en) * 1975-12-15 1977-08-30 Monsanto Company Triglycerides determination method
CA1114269A (en) * 1976-08-19 1981-12-15 Charles D. Warburton Integral element for the detection of glycerol or triglycerides
CA1100023A (en) * 1976-08-19 1981-04-28 Charles T. Goodhue Process and composition for the quantification of glycerol and triglycerides
US4275151A (en) * 1977-02-03 1981-06-23 Eastman Kodak Company Hydrolysis of protein-bound cholesterol esters
US4275152A (en) * 1977-02-03 1981-06-23 Eastman Kodak Company Hydrolysis of protein-bound cholesterol esters
JPS6058746B2 (en) * 1977-09-22 1985-12-21 中外製薬株式会社 Higher fatty acid ester
US4195126A (en) * 1977-10-04 1980-03-25 The Board Of Trustees Of The University Of Alabama Albumin-dye complex for fatty acid determination
US4245041A (en) * 1977-12-07 1981-01-13 American Monitor Corporation Triglycerides assay and reagents therefor
US4241178A (en) * 1978-01-06 1980-12-23 Eastman Kodak Company Process and composition for the quantification of glycerol ATP and triglycerides
US4223090A (en) * 1978-07-13 1980-09-16 American Hospital Supply Corporation Reagents for the enzymatic determination of triglycerides
DE2831580C2 (en) * 1978-07-18 1980-09-18 Boehringer Mannheim Gmbh, 6800 Mannheim Method and reagent for the determination of glycerin
DE2834704A1 (en) * 1978-08-08 1980-02-21 Boehringer Mannheim Gmbh METHOD FOR THE QUANTITATIVE ENZYMATIC DETERMINATION OF ADP
US4302536A (en) * 1978-08-15 1981-11-24 Longenecker Robert W Colorimetric immunoassay process
US4264589A (en) * 1978-12-20 1981-04-28 Felts James M Separation of active α1 -acid glycoprotein and utilization in the lipoprotein lipase enzyme system
US4178285A (en) * 1978-12-20 1979-12-11 Felts James M Separation of active α1 -acid glycoprotein and utilization in the lipoprotein lipase enzyme system
US4394445A (en) * 1979-02-22 1983-07-19 Nix Paul T Enzymatic glyceride hydrolysis
US4259440A (en) * 1979-05-21 1981-03-31 Miles Laboratories, Inc. Hydrolysis and assay of triglycerides
US4322496A (en) * 1980-04-17 1982-03-30 Eastman Kodak Company Inhibition of lactate oxidase
US4309502A (en) * 1980-06-30 1982-01-05 Beckman Instruments, Inc. Enzymatic assay for glycerol and triglycerides and a reagent for use therein
US4338395A (en) * 1980-07-21 1982-07-06 Technicon Instruments Corporation Method for the analysis of triglycerides
EP0045031A1 (en) * 1980-07-22 1982-02-03 Baker Instruments Corporation Glycerol detection reagent and its use
US4394444A (en) * 1982-06-21 1983-07-19 Miles Laboratories, Inc. Cofactor indicator compositions
JPS59140900A (en) * 1983-01-28 1984-08-13 Toyo Jozo Co Ltd Novel method for highly sensitive, enzymatic determination
JPS59196100A (en) * 1983-04-21 1984-11-07 Amano Pharmaceut Co Ltd Glycerol determination and composition therefor
US5310679A (en) * 1985-05-13 1994-05-10 Artiss Joseph D Composition for reducing turbidity in samples of biological fluids
US4626511A (en) * 1985-05-13 1986-12-02 Wayne State University Composition for reducing turbidity in samples of biological fluids
US20030186346A1 (en) * 2000-09-28 2003-10-02 Masayuki Yagi Process for producing protein decomposition product
JP4336886B2 (en) 2001-09-28 2009-09-30 アークレイ株式会社 Tetrazolium compound storage method, stabilizer used therefor, and tetrazolium compound reagent solution using the method
WO2004059315A1 (en) * 2002-12-24 2004-07-15 Stepan Company Method for determination of free and combined glycerin in biodiesel
WO2009077876A2 (en) * 2007-05-31 2009-06-25 Uti Limited Partnership Method for assessing trace element related disorders in blood plasma
EP2257646A1 (en) 2008-02-29 2010-12-08 ISIS Innovation Limited Diagnostic methods
US9817001B2 (en) 2008-05-27 2017-11-14 Boston Heart Diagnostics Corporation Methods for determining LDL cholesterol treatment
US8470541B1 (en) 2008-09-27 2013-06-25 Boston Heart Diagnostics Corporation Methods for separation and immuno-detection of biomolecules, and apparatus related thereto
EP2766728B1 (en) 2011-10-13 2017-09-06 Boston Heart Diagnostics Compositions and methods for treating and preventing coronary heart disease
US20140120559A1 (en) 2012-10-26 2014-05-01 Boston Heart Diagnostics Corporation Diabetes panel
US9828624B2 (en) 2013-07-24 2017-11-28 Boston Heart Diagnostics Corporation Driving patient compliance with therapy
EP3220810A4 (en) 2014-11-17 2018-05-16 Boston Heart Diagnostic Corporation Cardiovascular disease risk assessment

Also Published As

Publication number Publication date
FR2118454A5 (en) 1972-07-28
NL180523B (en) 1986-10-01
CA955161A (en) 1974-09-24
CS212729B2 (en) 1982-03-26
ES395956A1 (en) 1974-09-01
CH566003A5 (en) 1975-08-29
BR7108185D0 (en) 1973-05-31
GB1373106A (en) 1974-11-06
ZA717957B (en) 1972-08-30
DE2162325B2 (en) 1980-04-24
AU475955B2 (en) 1976-09-09
DE2162325C3 (en) 1980-12-11
IT972079B (en) 1974-05-20
NL7117275A (en) 1972-06-20
JPS549518B1 (en) 1979-04-25
US3703591A (en) 1972-11-21
IL38235A0 (en) 1972-01-27
AU3641671A (en) 1973-06-07
NL180523C (en) 1987-03-02
DE2162325A1 (en) 1972-06-22
SE389919B (en) 1976-11-22
JPS53114493A (en) 1978-10-05
CH563404A5 (en) 1975-06-30
BE776034A (en) 1972-03-16

Similar Documents

Publication Publication Date Title
US3703591A (en) Triglyceride hydrolysis and assay
Shimizu et al. Enzymatic microdetermination of serum free fatty acids
Werner et al. Ultramicro determination of serum triglycerides by bioluminescent assay.
CA1125151A (en) Triglycerides assay and reagents therefor
US4242446A (en) Method for determining a substance in a biological fluid and reagent combination for use in the method
US4259440A (en) Hydrolysis and assay of triglycerides
EP0695363B1 (en) Detection of biological material
US3898130A (en) Rapid enzymatic hydrolysis of triglycerides
US4906565A (en) Method for the selective detection of microbial nucleotides
CA1148456A (en) Process and reagent for determining triglycerides
DK144643B (en) METHOD AND REAGENT FOR DETERMINING TRIGLYCERIDES
GB2026156A (en) Determination of creatine kinase sub-unit B
US4338395A (en) Method for the analysis of triglycerides
US4394445A (en) Enzymatic glyceride hydrolysis
US4001089A (en) Method for determination of triglycerides and glycerol
EP0024578A1 (en) Method of stabilizing an enzyme solution for use in total cholesterol determination, stabilized solution and test kit therefor
US5962248A (en) Quantitative determination method for chloride ions
Fishman et al. Enzymes in analytical chemistry
US4206280A (en) Determination of acid phosphatase
US4056485A (en) Stable colored reference standard for enzymatic determinations
EP0089210B1 (en) Reagent for assaying cholinsterase
US4247633A (en) Reagent for colorimetric determination of creative phosphokinase
GB1590736A (en) Chemical assay method
Viallard et al. An ultramicro bioluminescence assay of enolase: application to human cerebrospinal fluid
US4142938A (en) Determination of triglycerides and glycerol